In search of antiepileptogenic treatments for post-traumatic epilepsy

Patricia G. Saletti, Idrish Ali, Pablo M. Casillas-Espinosa, Bridgette D. Semple, Christos Panagiotis Lisgaras, Solomon L. Moshe, Aristea S. Galanopoulou

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Post-traumatic epilepsy (PTE) is diagnosed in 20% of individuals with acquired epilepsy, and can impact significantly the quality of life due to the seizures and other functional or cognitive and behavioral outcomes of the traumatic brain injury (TBI) and PTE. There is no available antiepileptogenic or disease modifying treatment for PTE. Animal models of TBI and PTE have been developed, offering useful insights on the value of inflammatory, neurodegenerative pathways, hemorrhages and iron accumulation, calcium channels and other target pathways that could be used for treatment development. Most of the existing preclinical studies test efficacy towards pathologies of functional recovery after TBI, while a few studies are emerging testing the effects towards induced or spontaneous seizures. Here we review the existing preclinical trials testing new candidate treatments for TBI sequelae and PTE, and discuss future directions for efforts aiming at developing antiepileptogenic and disease-modifying treatments.

Original languageEnglish (US)
JournalNeurobiology of Disease
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Post-Traumatic Epilepsy
Seizures
Calcium Channels
Epilepsy
Iron
Animal Models
Quality of Life
Pathology
Hemorrhage
Traumatic Brain Injury

Keywords

  • Antiepileptogenesis
  • Disease modification
  • Inflammation
  • Iron
  • Neurodegeneration
  • Outcomes
  • Preclinical trial
  • Tau
  • Traumatic brain injury

ASJC Scopus subject areas

  • Neurology

Cite this

In search of antiepileptogenic treatments for post-traumatic epilepsy. / Saletti, Patricia G.; Ali, Idrish; Casillas-Espinosa, Pablo M.; Semple, Bridgette D.; Lisgaras, Christos Panagiotis; Moshe, Solomon L.; Galanopoulou, Aristea S.

In: Neurobiology of Disease, 01.01.2018.

Research output: Contribution to journalArticle

Saletti, Patricia G. ; Ali, Idrish ; Casillas-Espinosa, Pablo M. ; Semple, Bridgette D. ; Lisgaras, Christos Panagiotis ; Moshe, Solomon L. ; Galanopoulou, Aristea S. / In search of antiepileptogenic treatments for post-traumatic epilepsy. In: Neurobiology of Disease. 2018.
@article{5d24a7e8a28d470ba3175bd7c452268e,
title = "In search of antiepileptogenic treatments for post-traumatic epilepsy",
abstract = "Post-traumatic epilepsy (PTE) is diagnosed in 20{\%} of individuals with acquired epilepsy, and can impact significantly the quality of life due to the seizures and other functional or cognitive and behavioral outcomes of the traumatic brain injury (TBI) and PTE. There is no available antiepileptogenic or disease modifying treatment for PTE. Animal models of TBI and PTE have been developed, offering useful insights on the value of inflammatory, neurodegenerative pathways, hemorrhages and iron accumulation, calcium channels and other target pathways that could be used for treatment development. Most of the existing preclinical studies test efficacy towards pathologies of functional recovery after TBI, while a few studies are emerging testing the effects towards induced or spontaneous seizures. Here we review the existing preclinical trials testing new candidate treatments for TBI sequelae and PTE, and discuss future directions for efforts aiming at developing antiepileptogenic and disease-modifying treatments.",
keywords = "Antiepileptogenesis, Disease modification, Inflammation, Iron, Neurodegeneration, Outcomes, Preclinical trial, Tau, Traumatic brain injury",
author = "Saletti, {Patricia G.} and Idrish Ali and Casillas-Espinosa, {Pablo M.} and Semple, {Bridgette D.} and Lisgaras, {Christos Panagiotis} and Moshe, {Solomon L.} and Galanopoulou, {Aristea S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.nbd.2018.06.017",
language = "English (US)",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - In search of antiepileptogenic treatments for post-traumatic epilepsy

AU - Saletti, Patricia G.

AU - Ali, Idrish

AU - Casillas-Espinosa, Pablo M.

AU - Semple, Bridgette D.

AU - Lisgaras, Christos Panagiotis

AU - Moshe, Solomon L.

AU - Galanopoulou, Aristea S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Post-traumatic epilepsy (PTE) is diagnosed in 20% of individuals with acquired epilepsy, and can impact significantly the quality of life due to the seizures and other functional or cognitive and behavioral outcomes of the traumatic brain injury (TBI) and PTE. There is no available antiepileptogenic or disease modifying treatment for PTE. Animal models of TBI and PTE have been developed, offering useful insights on the value of inflammatory, neurodegenerative pathways, hemorrhages and iron accumulation, calcium channels and other target pathways that could be used for treatment development. Most of the existing preclinical studies test efficacy towards pathologies of functional recovery after TBI, while a few studies are emerging testing the effects towards induced or spontaneous seizures. Here we review the existing preclinical trials testing new candidate treatments for TBI sequelae and PTE, and discuss future directions for efforts aiming at developing antiepileptogenic and disease-modifying treatments.

AB - Post-traumatic epilepsy (PTE) is diagnosed in 20% of individuals with acquired epilepsy, and can impact significantly the quality of life due to the seizures and other functional or cognitive and behavioral outcomes of the traumatic brain injury (TBI) and PTE. There is no available antiepileptogenic or disease modifying treatment for PTE. Animal models of TBI and PTE have been developed, offering useful insights on the value of inflammatory, neurodegenerative pathways, hemorrhages and iron accumulation, calcium channels and other target pathways that could be used for treatment development. Most of the existing preclinical studies test efficacy towards pathologies of functional recovery after TBI, while a few studies are emerging testing the effects towards induced or spontaneous seizures. Here we review the existing preclinical trials testing new candidate treatments for TBI sequelae and PTE, and discuss future directions for efforts aiming at developing antiepileptogenic and disease-modifying treatments.

KW - Antiepileptogenesis

KW - Disease modification

KW - Inflammation

KW - Iron

KW - Neurodegeneration

KW - Outcomes

KW - Preclinical trial

KW - Tau

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=85049305403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049305403&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2018.06.017

DO - 10.1016/j.nbd.2018.06.017

M3 - Article

C2 - 29936231

AN - SCOPUS:85049305403

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -